TSHA
Taysha Gene Therapies Inc.
$4.19
+$0.20(+5.01%)
50
Overall
55
Value
45
Tech
--
Quality
Market Cap
$1.06B
Volume
4.39M
52W Range
$1.05 - $5.51
Target Price
$10.08
EPS Estimates Overview
| Current Quarter | $-0.11 | Next Quarter | $-0.1 |
| Current Year | $-0.37 | Next Year | $-0.43 |
| QoQ Growth | +9.1% | YoY Growth | -16.2% |
| 3Y EPS CAGR | +57.4% | Target Price | $10.08 |
| Consensus | Buy | Upside | +140.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $4.19 | +5.0% | 4.39M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW